Bullock Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.9K Buy
829
+3
+0.4% +$262 0.03% 241
2026
Q1
$70.5K Buy
826
+4
+0.5% +$357 0.04% 244
2025
Q4
$64.9K Buy
822
+5
+0.6% +$392 0.03% 239
2025
Q3
$64.6K Sell
817
-34
-4% -$2.9K 0.03% 243
2025
Q2
$78.3K Buy
851
+5
+0.6% +$456 0.04% 208
2025
Q1
$79.5K Sell
846
-969
-53% -$86.8K 0.04% 206
2024
Q4
$165K Sell
1,815
-108
-6% -$10.3K 0.1% 170
2024
Q3
$197K Buy
1,923
+8
+0.4% +$815 0.12% 145
2024
Q2
$183K Sell
1,915
-39
-2% -$3.6K 0.12% 142
2024
Q1
$174K Buy
+1,954
New +$166K 0.12% 153

Other funds holding CL

Bullock Wealth Management's CL Position: Q2 2026 in Review

Bullock Wealth Management increased its Colgate-Palmolive (CL) stake by 0.36% in Q2 2026, buying an estimated $262 and bringing the position to 829 shares worth $76.9K. The position accounts for 0.03% of the portfolio, ranked #241.

Bullock Wealth Management first reported a position in CL in Q1 2024 and has held it in 10 quarters since. The position peaked at $197K in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Bullock Wealth Management held 829 shares of Colgate-Palmolive worth $76.9K as of Q2 2026.
  • Bullock Wealth Management bought 3 Colgate-Palmolive shares in Q2 2026, an estimated $262.
  • Colgate-Palmolive made up 0.03% of Bullock Wealth Management's portfolio in Q2 2026, its #241 holding.
  • Bullock Wealth Management first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 10 quarters since.
  • Bullock Wealth Management's Colgate-Palmolive position peaked at $197K in Q3 2024.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.